Airway Management for Deep Sedation: Current Practice, Limitations, and Needs as Identified by Clinical Observation and Survey Results.
Airway complications
deep monitored anesthesia care (MAC)
deep sedation
oral and nasal airways
postoperative sore throat
Journal
AANA journal
ISSN: 2162-5239
Titre abrégé: AANA J
Pays: United States
ID NLM: 0431420
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
entrez:
3
4
2020
pubmed:
3
4
2020
medline:
12
1
2021
Statut:
ppublish
Résumé
Using deep sedation, adjunct airway devices such as oral or nasal airways are frequently required to maintain airway patency. Traditional oral airways (TOAs, made of rigid plastic) or nasal airways (made of pliable materials) can be associated with adverse effects, contributing to a trend of anesthesia providers placing nasal airways orally. A clinical observational study and an electronic provider survey were conducted to examine this emerging practice. The observation study objective was to investigate reported postoperative sore throat occurrence associated with use of either a nontraditional airway (nasal airway used orally) or TOA in deep sedation procedures (N = 243). Patients receiving nontraditional airways reported significantly less postoperative sore throat than those receiving TOAs (17% vs 40%, respectively; P < .001). These results prompted a broader exploration into airway practices of anesthesia providers via an electronic survey. Most respondents (n = 293) reported adverse effects, including gagging/coughing on insertion, oral cavity injury, and bleeding with TOAs. More than half (52.8%) reported using nasal airways orally. These results suggest a clinical void in current airway management options for deep sedation. Providers indicated the need for airway devices that provide a patent airway while mitigating adverse effects associated with commonly used airways.
Types de publication
Journal Article
Langues
eng
Pagination
123-129Informations de copyright
Copyright © by the American Association of Nurse Anesthetists.
Déclaration de conflit d'intérêts
Roxanne McMurray is the inventor of the McMurray Enhanced Airway and is vice president of clinical management at McMurray Medical, Minneapolis, Minnesota. Megan McMurray is the daughter of Roxanne McMurray but has no financial ties to McMurray Medical. The other authors have no financial relationships with any commercial interest related to the content of the article. The authors did discuss off-label use within the article.